| Literature DB >> 27490569 |
You-Hai Li1,2, Wen-Jin Han3, Xi-Wu Gui4, Tao Wei5, Shuang-Yan Tang6, Jian-Ming Jin7,8.
Abstract
Tentoxin, a cyclic tetrapeptide produced by several Alternaria species, inhibits the F₁-ATPase activity of chloroplasts, resulting in chlorosis in sensitive plants. In this study, we report two clustered genes, encoding a putative non-ribosome peptide synthetase (NRPS) TES and a cytochrome P450 protein TES1, that are required for tentoxin biosynthesis in Alternaria alternata strain ZJ33, which was isolated from blighted leaves of Eupatorium adenophorum. Using a pair of primers designed according to the consensus sequences of the adenylation domain of NRPSs, two fragments containing putative adenylation domains were amplified from A. alternata ZJ33, and subsequent PCR analyses demonstrated that these fragments belonged to the same NRPS coding sequence. With no introns, TES consists of a single 15,486 base pair open reading frame encoding a predicted 5161 amino acid protein. Meanwhile, the TES1 gene is predicted to contain five introns and encode a 506 amino acid protein. The TES protein is predicted to be comprised of four peptide synthase modules with two additional N-methylation domains, and the number and arrangement of the modules in TES were consistent with the number and arrangement of the amino acid residues of tentoxin, respectively. Notably, both TES and TES1 null mutants generated via homologous recombination failed to produce tentoxin. This study provides the first evidence concerning the biosynthesis of tentoxin in A. alternata.Entities:
Keywords: Alternaria alternata; cytochrome P450; nonribosome peptide synthetase; tentoxin
Mesh:
Substances:
Year: 2016 PMID: 27490569 PMCID: PMC4999850 DOI: 10.3390/toxins8080234
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Structure of tentoxin.
Figure 2Gene organization of the 30 kb DNA region near two clustered genes required for tentoxin biosynthesis in A. alternata ZJ33. The arrow and arrowhead indicate a predicted gene and its transcriptional direction; black arrows represent the genes required for tentoxin biosynthesis. ORF1–ORF4 encode four predicted proteins, respectively.
Figure 3Disruption of the TES or TES1 genes via homologous recombination. (A,C) Schematic diagram illustrating the targeted gene disruption strategy. WT, wild-type strain ZJ33; ΔTES TES null mutant; and ΔTES1, TES1 null mutant. (B) Verification of TES disruption by PCR analysis. Lanes 2–5: PCR amplification was performed using primer pairs TES-5for (F1) + Hyg-5rev (R1); lanes 7–10: PCR amplification was performed using primer pairs Hyg-3for (F2) + TES-3rev (R2); lanes 1, 6, and 11: DNA ladder markers; lanes 2 and 7: wild-type strain ZJ33; lanes 3–4 and 8–9: TES null mutants; lanes 5 and 10: ectopic transformants. (D) Verification of TES1 disruption by PCR. Lanes 2–5: PCR amplification was performed using primer pairs TES1-5for (F3) + Hyg-5rev (R1); lanes 7–10: PCR amplification was performed using primer pairs Hyg-3for (F2) + TES1-3rev (R3); lanes 1, 6, and 11: DNA ladder markers; lanes 2 and 7: wild-type strain ZJ33; lanes 3–4 and 8–9: TES1 null mutants; lanes 5 and 10: ectopic transformants. A 1.5 kilobase (kb) band was expected to be amplified from the genomic DNA of both the TES and TES1 null mutants by PCR. The sizes of standards are indicated on the right.
Figure 4HPLC analysis of tentoxin from A. alternata ZJ33 and transformants: (A) A. alternata ZJ33; (B) TES ectopic transformant; (C) TES1 ectopic transformant; (D) TES null mutant; (E) TES1 null mutant; and (F) Standard tentoxin. Retention time of tentoxin (Peak 1): 40.3 min.
Figure 5Putative binding-pocket constituents in the four adenylation domains of TES.
Signature sequences of amino acid in four putative adenylation domains of TES.
| Domain | Position | Substrate | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 235 | 236 | 239 | 278 | 299 | 301 | 322 | 330 | 331 | ||
| A1 | D | I | A | Q | V | G | V | I | W | Gly |
| A2 | D | V | W | F | C | G | G | T | F | Ala |
| A3 | D | A | L | L | V | G | A | V | S | Leu |
| A4 | D | G | W | F | L | A | A | V | M | DPhe |
Figure 6Schematic diagram of the modules in TES.
Primers used in this study.
| Primer a | Sequence b (5′→3′) |
|---|---|
| ITS4 | TCCTCCGCTTATTGATATGC |
| ITS5 | GGAAGTAAAAGTCGTAACAAGG |
| cps1 | AATCTAGATAYGGNCCNACNGA |
| cps2 | CCTCTAGANAGRTCNCCNGTYTTR |
| NRPS-for | GAGGCAAGGCAACCGCAACGATGA |
| NRPS-rev | CCCTTCATGTCGGGACTTGCGACA |
| CCGGGCTGCAGGAATTCGAT | |
| GGATCCCGGTCGGCATCTAC | |
| TES-5for | CGGGATCGCTACTGTTTGACGTCA |
| TES-5rev | |
| TES-3for | |
| TES-3rev | CATCGATCCCGATTGGCGTTCACA |
| TES-5nest | GAAGATATGGGAGAGAAACCGCGG |
| TES-3nest | AATGGTGGCATCGTTCTGGCCAGT |
| P450-5for | ACCTGACGAAACTCACTGCCTCCT |
| P450-5rev | |
| P450-3for | |
| P450-3rev | GCTCGACCATTGGATACCTAGCCT |
| P450-5nest | ACAATGGCCTAAGTCTGCCGCTCA |
| P450-3nest | CCCTCAACATTCCCTGGCATCTTG |
| Hyg-5rev | CGCACAAGTTATCGTGCACCAAGC |
| Hyg-3for | GGCGTATATGCTCCGCATTGGTCT |
a The name of target gene for disruption precedes the abbreviation of the primer names. -5for, the forward primer for amplification of the 5′-flanking region of a target gene; -5rev, the reverse primer for the 5′ region; -3for, the forward primer for the 3′ region; -3rev, the reverse primer for the 3′ region; -5nest, primer nested in -5′for; -3nest, primer nested in -3′rev; b The italic sequences are matched with the primer sequences of either HygB-for or HygB-rev.